Prevail Innovative Wealth Advisors, LLC Zoetis Inc. Transaction History

Prevail Innovative Wealth Advisors, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 08, 2024	BUY	$145.54 - $178.83 $1.11 Million - $1.36 Million	7,615 Added 40.13%	26,592 $4.61 Billion
Q1 2024 May 09, 2024	BUY	$165.67 - $199.94 $619,274 - $747,375	3,738 Added 24.53%	18,977 $3.21 Billion
Q4 2023 Feb 13, 2024	BUY	$151.44 - $200.09 $281,829 - $372,367	1,861 Added 13.91%	15,239 $3.01 Billion
Q3 2023 Nov 14, 2023	BUY	$167.14 - $192.77 $819,153 - $944,765	4,901 Added 57.82%	13,378 $2.33 Billion
Q2 2023 Aug 15, 2023	BUY	$160.94 - $186.23 $1.36 Million - $1.58 Million	8,477 New	8,477 $1.46 Billion

1,957

412M

1.02M

1.09M

Ticker ZTS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 468,139,008
Market Cap $82.7B
Description
Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...

Get notified when there are updates to the investment portfolio of Prevail Innovative Wealth Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Prevail Innovative Wealth Advisors, LLC with notifications on news.